ASBPW - Aspire Biopharma Holdings, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

ASBPW

ASPIRE BIOPHARMA HOLDINGS, INC.

NASDAQ

$0.02

▲ UP 31.33% (0.00)

KEY STATISTICS

Market Cap$226.59 K

52w High$0.04

52w Low$0.01

Dividend Yield—

Frequency—

P/E—

Volume100

Shares Out.11.50M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Kraig T. Higginson

ABOUT

SECTOR

Healthcare

WENT PUBLIC

April 11, 2022

METHOD OF GOING PUBLIC

SPAC

FULL TIME EMPLOYEES

SPLIT RECORD

DATE	TYPE	RATIO
2026-05-11	Reverse	1:30

PRICE

$0.02 ▲ UP 31.33% (+$0.00)

OVERLAYS

About Aspire Biopharma Holdings, Inc.

https://aspirebiolabs.com ↗

Aspire Biopharma Holdings, Inc. is a biotechnology firm developing advanced diagnostic and molecular testing solutions using cutting-edge genetics and biochemistry research to support healthcare and life sciences.

INDUSTRY

Biotechnology

A PRODUCT ASPIRE BIOPHARMA HOLDINGS, INC. IS KNOWN FOR

BUZZ BOMB™

BUZZ BOMB™ is Aspire Biopharma's flagship sublingual caffeine supplement offering rapid absorption and cognitive enhancement, demonstrating their innovative delivery technology while their main drug candidates are in development.